Weiss Multi Strategy Advisers LLC Seagen Inc. Transaction History

Weiss Multi Strategy Advisers LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $5.37 Million - $5.9 Million	-28,607 Reduced 65.27%	15,225 $2.93 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $102,327 - $162,870	802 Added 1.86%	43,832 $8.88 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $1.37 Million - $1.63 Million	-11,692 Reduced 21.37%	43,030 $5.53 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $1 Million - $1.33 Million	-7,396 Reduced 11.91%	54,722 $7.49 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $1.5 Million - $2.48 Million	13,810 Added 28.59%	62,118 $11 Million

Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $2.08 Million - $2.74 Million	17,373 Added 56.16%	48,308 $6.96 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $9,267 - $12,405	-65 Reduced 0.21%	30,935 $4.78 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $121,509 - $144,856	853 Added 2.83%	31,000 $5.26 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $145,886 - $173,988	1,080 Added 3.72%	30,147 $4.76 Million
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $1.21 Million - $1.68 Million	8,798 Added 43.41%	29,067 $4.04 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $3.34 Million - $4.3 Million	20,269 New	20,269 $3.55 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.